Intrinsic Value of S&P & Nasdaq Contact Us

BlackRock Science and Technology Trust II BSTZ NYSE

NYSE • Financial Services • Asset Management • US • USD

SharesGrow Score
81/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

BlackRock Science and Technology Trust II (BSTZ) generated $-33.33M in operating cash flow for quarter ending 2025-12-31. After capital expenditures of $3.00, free cash flow was $-33.33M.

Free cash flow margin was -23.7% of revenue. Cash conversion ratio was -0.12x, suggesting some earnings are non-cash.

Criteria supported by this page:

  • HEALTH (100/100, Pass) — demonstrate the company can comfortably service its debt
  • MOAT (55/100, Partial) — cash flow generation is present but not at levels indicating a wide moat
  • INCOME (100/100) — Cash conversion ratio was -0.12x suggests some earnings are non-cash items

Overall SharesGrow Score: 79/100 with 3/7 criteria passed.

SharesGrow 7-Criteria Score
81/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
→ Valuation
FUTURE
N/A
No coverage
~
PAST
75/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
Proven by this page
~
MOAT
55/100
Proven by this page
~
GROWTH
58/100
→ Income
INCOME
100/100
→ Income
BlackRock Science and Technology Trust II Cash Flow History
Metric TTM Q4 FY2025 Q2 FY2025 Q4 FY2024 Q2 FY2024
Operating Cash Flow $-139.07M$-33.33M$-14.42M$-34.8M$-56.52M
Capital Expenditure $1.00$-3.00$0.00$2.00$2.00
Free Cash Flow $-139.07M$-33.33M$-14.42M$-34.8M$-56.52M
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message